1799952-48-9 Usage
Uses
Used in Pharmaceutical Industry:
(S)-N-(2,4-difluorobenzyl)-2'-ethyl-9'-hydroxy-1',8'-dioxo-1',2,2',4,4',5,6,8'-octahydrospiro[pyran-3,3'-pyrido[1,2-a]pyrazine]-7'-carboxamide is used as a potential pharmaceutical agent for its possible biological activity due to the presence of various functional groups and ring structures.
Used in Chemical Research:
In the field of chemical research, (S)-N-(2,4-difluorobenzyl)-2'-ethyl-9'-hydroxy-1',8'-dioxo-1',2,2',4,4',5,6,8'-octahydrospiro[pyran-3,3'-pyrido[1,2-a]pyrazine]-7'-carboxamide can be used as a subject for studying the effects of its unique structure on its properties and potential reactivity with other molecules, which could lead to the development of new chemical processes or applications.
Used in Drug Design and Development:
(S)-N-(2,4-difluorobenzyl)-2'-ethyl-9'-hydroxy-1',8'-dioxo-1',2,2',4,4',5,6,8'-octahydrospiro[pyran-3,3'-pyrido[1,2-a]pyrazine]-7'-carboxamide's structure, featuring a spiro ring and multiple functional groups, makes it a candidate for drug design and development. It may be utilized in the creation of new drugs targeting specific biological pathways or receptors, pending further investigation into its biological interactions and efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 1799952-48-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,9,9,9,5 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1799952-48:
(9*1)+(8*7)+(7*9)+(6*9)+(5*9)+(4*5)+(3*2)+(2*4)+(1*8)=269
269 % 10 = 9
So 1799952-48-9 is a valid CAS Registry Number.
1799952-48-9Relevant academic research and scientific papers
SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
-
Page/Page column 93; 94, (2015/07/07)
The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, X, Y, R1, R2 and R11 are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.
